But here we are. Executives across the industry are working tirelessly to devise and execute a model in which pharma sales representatives and other customer facing roles balance face-to-face (F2F), remote, and digital engagement, whilst also considering to what extent the roles themselves must be adapted for the new normal.
Many questions remain unanswered:
Â
How can we ensure that we are reaching HCPs at a time and place where they can truly engage?
What is the right balance of F2F and remote engagement?
How do you create and maintain new relationships in the remote environment?
How can we demonstrate what does - and doesn’t - and rapidly adapt and improve?
Join this exclusive webinar as we discuss the future of hybrid HCP engagement and go-to-market models. Key learnings include:
How can we ensure that we are reaching HCPs at a time and place where they can truly engage?
What is the right balance of F2F and remote engagement?
How do you create and maintain new relationships in the remote environment?
How can we demonstrate what does - and doesn’t - and rapidly adapt and improve?
Join this exclusive webinar as we discuss the future of hybrid HCP engagement and go-to-market models. Key learnings include:
